ADVFN Logo
Boards:
    Quotes:
      Boards
      News
      Market Data
      Markets
      Discover
      Subscribe Login/Register Profile Icon
      S&P 500
      5,011.12
      -0.22%
      US Tech 100
      16,902.40
      -0.77%
      Dow Jones
      37,775.38
      0.06%
      Brent Oil
      86.415
      -0.66%
      Bitcoin
      63,516.00
      3.64%
      Registration Strip Icon for charts Register for streaming realtime charts, analysis tools, and prices.
      Get Started
      1. Home
      2. Investing
      3. Stocks
      4. USA
      5. NASDAQ
      6. BriaCell Therapeutics Corporation (BCTX)

      7. BriaCell Therapeutics Corporation (BCTX) News

      BCTX

      BriaCell Therapeutics (BCTX)

      BriaCell Therapeutics Corporation
      		Date:
      Sort by:
       Showing the most relevant articles for your search:NASDAQ:BCTX
      DateTimeSourceHeadlineSymbolCompany
      04/10/20248:00AMGlobeNewswire Inc.BriaCell 2024 AACR Preclinical Poster Confirms Strong Anti-Cancer Activity of Bria-OTS+™ and Bria-PROS+™ Clinical Candidates for Breast and Prostate CancerNASDAQ:BCTXBriaCell Therapeutics Corporation
      04/09/20248:00AMGlobeNewswire Inc.BriaCell Showcases Data Demonstrating Unmatched Progression-Free Survival (PFS) and Clinical Efficacy in Antibody-Drug Conjugate (ADC) Resistant and Central Nervous System (CNS) Metastatic Breast Cancer at the 2024 AACRNASDAQ:BCTXBriaCell Therapeutics Corporation
      03/07/20248:00AMGlobeNewswire Inc.BriaCell Receives and Executes Letter of Intent to Advance Clinical Development of Breast and Prostate Cancer ImmunotherapiesNASDAQ:BCTXBriaCell Therapeutics Corporation
      03/06/20248:00AMGlobeNewswire Inc.BriaCell to Present Clinical Data in Central Nervous System (CNS) Metastasis and Antibody-Drug Conjugate (ADC) Resistant Breast Cancer at the 2024 AACR ConferenceNASDAQ:BCTXBriaCell Therapeutics Corporation
      02/27/20248:00AMGlobeNewswire Inc.BriaCell Provides Update on Alleged Illegal Trading of Public SecuritiesNASDAQ:BCTXBriaCell Therapeutics Corporation
      02/07/20248:00AMGlobeNewswire Inc.BriaCell Announces Strong Clinical Data in Breast Cancer Patients; Reports Another Notable Responder CaseNASDAQ:BCTXBriaCell Therapeutics Corporation
      02/06/20248:30AMGlobeNewswire Inc.Breaking Ground in Prostate Cancer: BriaCell Announces Lead Prostate Cancer Candidate Bria-Pros+, Initiates GMP ManufacturingNASDAQ:BCTXBriaCell Therapeutics Corporation
      02/01/202412:15AMEdgar (US Regulatory)Form EFFECT - Notice of EffectivenessNASDAQ:BCTXBriaCell Therapeutics Corporation
      01/31/20245:24PMEdgar (US Regulatory)Form 8-K - Current reportNASDAQ:BCTXBriaCell Therapeutics Corporation
      01/30/202410:48PMGlobeNewswire Inc.BriaCell Therapeutics Corp. Announces Results of Shareholder MeetingNASDAQ:BCTXBriaCell Therapeutics Corporation
      01/22/20245:00PMEdgar (US Regulatory)Form S-3 - Registration statement under Securities Act of 1933NASDAQ:BCTXBriaCell Therapeutics Corporation
      01/09/20244:05PMEdgar (US Regulatory)Form DEF 14A - Other definitive proxy statementsNASDAQ:BCTXBriaCell Therapeutics Corporation
      01/08/202411:01AMEdgar (US Regulatory)Form SCHEDULE 13G -NASDAQ:BCTXBriaCell Therapeutics Corporation
      01/04/20248:45AMGlobeNewswire Inc.BriaCell Images Confirm Robust Anti-Tumor Activity in Patient with “Eye-Bulging” Metastatic Breast CancerNASDAQ:BCTXBriaCell Therapeutics Corporation
      12/28/20238:55AMGlobeNewswire Inc.BriaCell Reports 71% Central Nervous System Response Rate in Advanced Breast Cancer PatientsNASDAQ:BCTXBriaCell Therapeutics Corporation
      12/20/20234:05PMEdgar (US Regulatory)Form 8-K - Current reportNASDAQ:BCTXBriaCell Therapeutics Corporation
      12/20/20238:40AMGlobeNewswire Inc.BriaCell Reports Unprecedented Preliminary Survival and Clinical Benefit in Antibody-Drug Conjugate (ADC) Refractory Patient SubsetNASDAQ:BCTXBriaCell Therapeutics Corporation
      12/14/20235:00PMEdgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]NASDAQ:BCTXBriaCell Therapeutics Corporation
      12/14/20235:00PMEdgar (US Regulatory)Form 8-K - Current reportNASDAQ:BCTXBriaCell Therapeutics Corporation
      12/06/20239:31AMGlobeNewswire Inc.BriaCell Highlights Outstanding Topline Survival and Clinical Benefit Data in Advanced Metastatic Breast Cancer at the 2023 SABCSNASDAQ:BCTXBriaCell Therapeutics Corporation
      12/06/20239:00AMGlobeNewswire Inc.BriaCell 2023 SABCS Posters Confirm Activation of Cancer-Fighting Immune Cells and Identify Potential Predictors of Clinical BenefitNASDAQ:BCTXBriaCell Therapeutics Corporation
      11/30/20237:00AMEdgar (US Regulatory)Form 8-K - Current reportNASDAQ:BCTXBriaCell Therapeutics Corporation
      11/30/20237:00AMGlobeNewswire Inc.BriaCell Records New Responder with Remarkable Improvement of “Eye-Bulging” Metastatic TumorNASDAQ:BCTXBriaCell Therapeutics Corporation
      11/03/20238:31AMGlobeNewswire Inc.BriaCell Reports Unprecedented Anti-Tumor Activity of its Next Generation Personalized Breast and Prostate Cancer Immunotherapies in Tumor Models at the 2023 SITC Annual Meeting; FDA Greenlights Bria-OTS™ INDNASDAQ:BCTXBriaCell Therapeutics Corporation
      10/25/20239:15AMGlobeNewswire Inc.BriaCell Forms Medical Advisory Board of Distinguished Breast Cancer Specialists to Advance its Lead Oncology CandidateNASDAQ:BCTXBriaCell Therapeutics Corporation
      10/20/20239:15AMGlobeNewswire Inc.October is Breast Cancer Awareness Month – BriaCell is Leading the Fight with its Innovative TechnologyNASDAQ:BCTXBriaCell Therapeutics Corporation
      10/18/20239:00AMGlobeNewswire Inc.BriaCell Announces Presentations at the 2023 Society for the Immunotherapy of Cancer (SITC) and San Antonio Breast Cancer (SABC) ConferencesNASDAQ:BCTXBriaCell Therapeutics Corporation
      10/11/20239:10AMGlobeNewswire Inc.BriaCell To Host Virtual Key Opinion Leader Event on Bria-IMT™ Potential in Advanced Metastatic Breast Cancer on October 26, 2023 Featuring Dr. Adam M. Brufsky from University of Pittsburgh School of Medicine and Dr. Saranya Chumsri from Mayo ClinicNASDAQ:BCTXBriaCell Therapeutics Corporation
      10/04/20239:00AMGlobeNewswire Inc.BriaCell Partners with New York Cancer & Blood Specialists (NYCBS) for Pivotal Phase 3 Study of Bria-IMT™ in Advanced Breast CancerNASDAQ:BCTXBriaCell Therapeutics Corporation
      10/03/20239:00AMGlobeNewswire Inc.BriaCell Initiates Pivotal Phase 3 Study of Bria-IMT™ in Advanced Metastatic Breast CancerNASDAQ:BCTXBriaCell Therapeutics Corporation
       Showing the most relevant articles for your search:NASDAQ:BCTX